Our previous research identified hypermethylated PCDHGB7 as a novel cancer marker with discernible value for early cervical cancer detection and modified methylation-sensitive restriction enzyme qPCR (MSRE-qPCR) to quantify its methylation status [32]. The gene discussed is PCDHGB7; the disease is cervical cancer.